Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes-Alvarez, Nathaly Limon-de la Rosa, Moisés Salgado-de la Mora, Paola Valdez-Sandoval, Mildred Palacios-Jiménez, Fátima Rodriguez-Alvarez, Brenda I. Vera-Maldonado, Eduardo Aguirre-Aguilar, Juan Manuel Escobar-Valderrama, Jorge Alanis-Mendizabal, Osvely Méndez-Guerrero, Farid Tejeda-Dominguez, Jiram Torres-Ruíz, Diana Gómez-Martín, Kathryn L Colborn, David Kershenobich, Christene A Huang, View ORCID ProfileNalu Navarro-Alvarez
doi: https://doi.org/10.1101/2021.02.07.21251281
Eduardo Cervantes-Alvarez
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
5PECEM, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico
Nathaly Limon-de la Rosa
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
Moisés Salgado-de la Mora
2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Internal Medicine, Mexico City, Mexico
Paola Valdez-Sandoval
2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Internal Medicine, Mexico City, Mexico
Mildred Palacios-Jiménez
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
6Universidad Veracruzana, Veracruz, Mexico
Fátima Rodriguez-Alvarez
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
6Universidad Veracruzana, Veracruz, Mexico
Brenda I. Vera-Maldonado
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
6Universidad Veracruzana, Veracruz, Mexico
Eduardo Aguirre-Aguilar
2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Internal Medicine, Mexico City, Mexico
Juan Manuel Escobar-Valderrama
2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Internal Medicine, Mexico City, Mexico
Jorge Alanis-Mendizabal
2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Internal Medicine, Mexico City, Mexico
Osvely Méndez-Guerrero
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
Farid Tejeda-Dominguez
4Universidad Panamericana School of Medicine, Campus México, Mexico City
Jiram Torres-Ruíz
3Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Immunology and Rheumatology, Mexico City, Mexico
Diana Gómez-Martín
3Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Immunology and Rheumatology, Mexico City, Mexico
Kathryn L Colborn
7Department of Surgery, University of Colorado Anschutz Medical Campus, Denver, CO
David Kershenobich
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
Christene A Huang
7Department of Surgery, University of Colorado Anschutz Medical Campus, Denver, CO
Nalu Navarro-Alvarez
1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Department of Gastroenterology, Mexico City, Mexico
4Universidad Panamericana School of Medicine, Campus México, Mexico City
7Department of Surgery, University of Colorado Anschutz Medical Campus, Denver, CO
Article usage
Posted February 09, 2021.
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes-Alvarez, Nathaly Limon-de la Rosa, Moisés Salgado-de la Mora, Paola Valdez-Sandoval, Mildred Palacios-Jiménez, Fátima Rodriguez-Alvarez, Brenda I. Vera-Maldonado, Eduardo Aguirre-Aguilar, Juan Manuel Escobar-Valderrama, Jorge Alanis-Mendizabal, Osvely Méndez-Guerrero, Farid Tejeda-Dominguez, Jiram Torres-Ruíz, Diana Gómez-Martín, Kathryn L Colborn, David Kershenobich, Christene A Huang, Nalu Navarro-Alvarez
medRxiv 2021.02.07.21251281; doi: https://doi.org/10.1101/2021.02.07.21251281
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes-Alvarez, Nathaly Limon-de la Rosa, Moisés Salgado-de la Mora, Paola Valdez-Sandoval, Mildred Palacios-Jiménez, Fátima Rodriguez-Alvarez, Brenda I. Vera-Maldonado, Eduardo Aguirre-Aguilar, Juan Manuel Escobar-Valderrama, Jorge Alanis-Mendizabal, Osvely Méndez-Guerrero, Farid Tejeda-Dominguez, Jiram Torres-Ruíz, Diana Gómez-Martín, Kathryn L Colborn, David Kershenobich, Christene A Huang, Nalu Navarro-Alvarez
medRxiv 2021.02.07.21251281; doi: https://doi.org/10.1101/2021.02.07.21251281
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)